Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

NCT00404170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

396

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: B-CIT and SPECT imaging

Sponsor

Institute for Neurodegenerative Disorders

Collaborators

[object Object]